Subsequent experiments manipulating TREM2 expression have shown that it promotes the phagocytosis of Aβ and suppresses Aβ-induced proinflammatory responses, thereby improving neuropathology and enhancing spatial cognitive function in AD [198]. The gene discussed is TREM2; the disease is Alzheimer disease.